my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
15-Jun-2021 In addition to plaques that accumulate outside of nerve cells in the brain, Alzheimer’s disease is also characterised by changes inside these cells. Researchers from the Cell Signalling research group at the Chair of Molecular Biochemistry at RUB, headed by Dr. Thorsten Müller, have been st ... more
15-Jun-2021 Using chemical synthesis, Bright Peak Therapeutics can produce proteins that have never before existed. This holds great potential for cancer immunotherapy. The Basel-based spin-off has its beginnings at ETH Zurich. Jeffrey Bode’s long, bold journey began over an after-work beer in Tokyo ... more
15-Jun-2021 For the first time in the world, researchers at Tel Aviv University developed an innovative nanotechnology that transforms a transparent calcite nanoparticle into a sparkling gold-like particle. In other words, they turned the transparent particle into a particle that is visible despite its ... more
15-Jun-2021 Both during and after infection with the Coronavirus SARS-CoV-2, patients may suffer from severe neurological symptoms, including “anosmia”, the loss of taste and smell typically associated with COVID-19. Along with direct damage caused by the virus, researchers suspect a role for excessive ... more
14-Jun-2021 Viruses have always had a major influence on life. They emerged a few billion years ago, precisely when is difficult to estimate. There are also several theories as to how viruses originated. While exploring one possibility, researchers at ETH Zurich have managed to recapitulate a potential ... more
14-Jun-2021 Cardiovascular diseases are the most common cause of death in Germany. Important triggers for this are stress, lack of exercise and an unhealthy diet. Now a research team led by Professor Dr. Dietmar Manstein, Director of the Institute of Biophysical Chemistry at Hannover Medical School (MH ... more
14-Jun-2021 Tuberculosis is still the infectious disease that is responsible for the highest number of deaths worldwide. It is caused by Mycobacterium tuberculosis, a bacterium that infects cells in the lungs. There, the pathogen is hardly accessible to most antibiotics. In addition, resistance to exis ... more
14-Jun-2021 Researchers have discovered that the common bacteria E. coli can be deployed as a sustainable way to convert post-consumer plastic into vanillin, a new study reveals. Vanillin is the primary component of extracted vanilla beans and is responsible for the characteristic taste and smell of va ... more
11-Jun-2021 In response to the investment boom in the pharmaceutical industry, TTP Group is opening another Pharmaplan branch in Switzerland in the third quarter of 2021. With the new subsidiary at the biotech site in Visp, Pharmaplan is meeting the growing global demand for pharmaceutical engineering ... more
11-Jun-2021 Evonik is working with Stanford University on a technology to deliver mRNA to tissues and organs that goes beyond the capabilities of lipid nanoparticles (LNPs). This polymer-based platform complements Evonik’s existing portfolio of lipid-based drug delivery, including LNPs. Starting this m ... more
09-Jun-2021 Biomolecules regulate the biological functions inside every living cell. If scientists can understand the molecular mechanisms of such functions, then it is possible to detect severe dysfunction which can lead to illness. At a molecular level, this can be achieved with fluorescent markers t ... more
07-Jun-2021 Our proteome is much bigger than our genome because one gene produces several variants of proteins called protein isoforms, whose disbalance is implicated in many diseases. A new bioengineered reporter system developed at Helmholtz Zentrum München and the Technical University of Munich now ... more
02-Jun-2021 Molecular analysis of single cells provides an important basis for precision medicine. Five years ago, scientists around the world came together to pursue the “Human Cell Atlas” project, with the aim of cataloging all cells in the human body. These data have helped, for example, to identify ... more
28-May-2021 In pharmaceutical research, small tissue spheres are used as mini-organ models for reproducible tests. TU Wien has found a way to develop a reliable standard for these tissue samples. Before drugs are tested in clinical trials, they must be tested either by animal experiments or, more recen ... more
28-May-2021 When researchers at ETH Zurich compared the reference genomes between several breeds of domestic cattle and closely related wild cattle, they discovered genes with previously unknown functions. Modern genetic research often works with what are known as reference genomes. Such a genome compr ... more
03-May-2021 Researchers at the University of Bonn and the research center caesar have succeeded in ultra-fast freezing proteins after a precisely defined period of time. They were able to follow structural changes on the microsecond time scale and with sub-nanometer precision. Owing to its high spatial ... more
30-Apr-2021 The international Vertebrate Genomes Project (VGP) publishes their flagship study focused on genome assembly quality and standardization for the field of genomics in a special issue of Nature, along with 20 associated publications. This study presents 16 diploid high-quality, near error-fre ... more
29-Apr-2021 Researchers at the University Zurich have mapped the first complete atlas of single cells that make up the human teeth. Their research shows that the composition of human dental pulp and periodontium vary greatly. Their findings open up new avenues for cell-based dental therapeutic approach ... more
20-Apr-2021 What exactly happens when the corona virus SARS-CoV-2 infects a cell? In an article published in Nature, a team from the Technical University of Munich (TUM) and the Max Planck Institute of Biochemistry paints a comprehensive picture of the viral infection process. For the first time, the i ... more
12-Apr-2021 Fuels such as kerosene or diesel can be contaminated by fungi or bacteria. The microorganisms settle in the liquid itself, on the inner walls of tanks and pipes or in fuel filters and feed on carbon atoms. Since the fungi and bacteria multiply well in this environment, they can form a strea ... more
15-Jun-2021 Using chemical synthesis, Bright Peak Therapeutics can produce proteins that have never before existed. This holds great potential for cancer immunotherapy. The Basel-based spin-off has its beginnings at ETH Zurich. Jeffrey Bode’s long, bold journey began over an after-work beer in Tokyo ... more
14-Jun-2021 Researchers have discovered that the common bacteria E. coli can be deployed as a sustainable way to convert post-consumer plastic into vanillin, a new study reveals. Vanillin is the primary component of extracted vanilla beans and is responsible for the characteristic taste and smell of va ... more
11-Jun-2021 Evonik is working with Stanford University on a technology to deliver mRNA to tissues and organs that goes beyond the capabilities of lipid nanoparticles (LNPs). This polymer-based platform complements Evonik’s existing portfolio of lipid-based drug delivery, including LNPs. Starting this m ... more
10-Jun-2021 High-value chemicals used in biofuels and pharmaceuticals can be made from bacteria by switching their chemistry to produce novel products. Researchers from the University of Warwick have found a way to drastically cut the cost of turning on these switches.We use chemicals for almost everyt ... more
09-Jun-2021 CyGenica has announced that it has raised USD $1.4 million in a seed fund investment round, led by global venture capital investor SOSV. The funding round will accelerate validation of CyGenica’s proprietary technology which enables safe, targeted and affordable intercellular drug delivery. ... more
07-Jun-2021 The number of data-transmitting microdevices, for instance in packaging and transport logistics, will increase sharply in the coming years. All these devices need energy, but the amount of batteries would have a major impact on the environment. Empa researchers have developed a biodegradabl ... more
07-Jun-2021 Our proteome is much bigger than our genome because one gene produces several variants of proteins called protein isoforms, whose disbalance is implicated in many diseases. A new bioengineered reporter system developed at Helmholtz Zentrum München and the Technical University of Munich now ... more
03-Jun-2021 In general, plastics are processed at way over a hundred degrees Celsius. Enzymes, by contrast, cannot usually withstand these high temperatures. Researchers at the Fraunhofer Institute for Applied Polymer Research IAP have managed to reconcile these contradictions: They are able to embed e ... more
02-Jun-2021 Origin.Bio-- a synthetic biology company that replicates and improves ingredients from traditional chemical industrialisation processes, freeing manufacturers from petrochemical dependency -- today announces a $15m funding round led by EQT Ventures. Existing investor BlueYard Capital also p ... more
02-Jun-2021 Exploiting the unusual metal-reducing ability of the iron-breathing bacterium Geobacter sulfurreducens, KAUST researchers have demonstrated a cheap and reliable way to synthesize highly active single-atom catalysts. The innovation, which could dramatically improve the efficiency and cost of ... more
11-Jun-2021 Information technology can make life easier in many areas – including research. In medicine, for example, it is still standard practice to evaluate microscopy images of tissue sections by hand. This is used, for example, to assess how many cancer cells are in a lymph node. "You often sit in ... more
20-May-2021 The COVID-19 pandemic made it clear technological innovations were urgently needed to detect, treat, and prevent the SARS-CoV-2 virus. A year and a half into this epidemic, waves of successive outbreaks and the dire need for new medical solutions -- especially testing -- continue to exist. ... more
19-May-2021 PerkinElmer, Inc. and Immunodiagnostic Systems Holdings PLC (IDS) announced that they have reached an agreement on the terms of a recommended all cash offer whereby PerkinElmer will acquire IDS for approximately $155 million (£110 Million). The transaction has a total enterprise value of ap ... more
12-May-2021 Start-up InsectSense and Wageningen Bioveterinary Research have trained bees to extend their tongues when they smell the coronavirus. The coronavirus, like other diseases, causes metabolic changes in the body that causes a smell. Bees can be trained within minutes to recognize the scent of ... more
12-May-2021 The European Patent Office (EPO) announces that Italian engineer Marco Donolato and team have been nominated as finalists in the "Research" category of the European Inventor Award 2021 for their novel testing device which detects infectious diseases within minutes, enabling medical staff to ... more
10-May-2021 Severe cases of COVID-19 can now be detected at an early stage. Researchers at the University of Zurich have identified the first biomarker that can reliably predict which patients will develop severe symptoms. This can help to improve the treatment of severe cases of COVID-19. Most people ... more
03-May-2021 osteolabs GmbH announces the formation of osteolabs UK Limited in Marlow near London. osteolabs UK is a Joint Venture between osteolabs GmbH as majority shareholder and Christopher Brain, an experienced Medtech business professional with a track record of well over 15 years with some leadin ... more
29-Apr-2021 Am I infected with SARS-CoV-2? Is it one of the dangerous variants? Being able to answer these and more questions with a single efficient diagnostic test can be decisive for gauging the spread of disease and selecting the right therapy. In a study published in the journal "Science", researc ... more
28-Apr-2021 Based on analysing chemical elements the methodology, which has been adapted from an analytical technique used to identify metallic nanoparticles, is able to detect the presence of viruses within just 20 seconds. Although the tests would need to be performed in a lab, it could be used to qu ... more
23-Apr-2021 The biotechnology company oncgnostics GmbH is researching a method for diagnosing Head-and-Neck tumors together with the clinical department for general ENT at the Medical University of Graz as part of the “OroCa-Graz” study. 550,000 people worldwide develop carcinomas of this type every ye ... more
10-Jun-2021 Strateos, Inc., a pioneer in the development of remote access laboratories and lab control software for life science research, announced the closing of its $56.1 million Series B financing led by DCVC and Lux Capital with participation from new investors including Eli Lilly and Company, All ... more
31-May-2021 Pipettes are important tools for scientists when transporting liquids in medical, pharmaceutical, biology, and chemistry laboratories. Using pipettes precisely is especially important when repeating experiments. The University of Freiburg researchers Julius Wiener, Tobias Zundel, and Oliver ... more
14-May-2021 PerkinElmer, Inc. announced it has entered into an agreement to acquire Nexcelom Bioscience for $260 Million in cash. The transaction is expected to close during the second quarter of 2021.Nexcelom is a global provider of automated cell counting instruments, image cytometry workstations, as ... more
06-May-2021 In fiscal year 2020, Eppendorf AG succeeded in posting record revenue of €967 million (prior year: €804 million) – a significant year-on-year increase of 20.3% (prior year: 10.2%). EBIT likewise saw a sharp rise of €73.5 million to €217.7 million (prior year: €144.2 million), representing a ... more
06-May-2021 With the successful completion of a second closing, Labforward adds >€3m to the Series B from January, bringing the total funds raised to >€8.5m. The majority of the new investment comes from the Fielmann Family Office, majority owner of the leading German family business of the same name t ... more
18-Mar-2021 LAUDA will cooperate with Better Basics Laborbedarf GmbH (BBL). The Dresden-based company, founded in 2019, develops, manufactures and sells smart basic equipment for laboratories that simplifies the organization of laboratory workstations and supports laboratory employees in their daily wo ... more
29-Jan-2021 Sartorius recorded high growth according to preliminary figures in 2020 due to strong organic development, several acquisitions and the additional momentum from business related to the coronavirus pandemic. The Group closed the year with significant double-digit growth rates in sales revenu ... more
12-Jan-2021 Labforward has closed a new financing round. The laboratory equipment manufacturers Tecan and 2mag as well as existing investor Peppermint Venture Partners are investing more than € 5 million in the laboratory software company with headquarters in Berlin. Laboratories face the challenge of ... more
25-Nov-2020 In September, the current situation will be less critical - this is the opinion of the vast majority of LABVOLUTION exhibitors. Although there would have been an elaborate security concept for the original date in May, the organizers of Deutsche Messe AG are now postponing the trade show fo ... more
24-Nov-2020 analytica China 2020 came to a successful conclusion on November 18, 2020 at the Shanghai New International Expo Centre. The show brought together 1,009 exhibitors (2018: 950) and 112 represented companies and partners. 23,652 professional visitors attended. With six exhibition halls, eight ... more
11-Jun-2021 In response to the investment boom in the pharmaceutical industry, TTP Group is opening another Pharmaplan branch in Switzerland in the third quarter of 2021. With the new subsidiary at the biotech site in Visp, Pharmaplan is meeting the growing global demand for pharmaceutical engineering ... more
11-Jun-2021 Evonik is working with Stanford University on a technology to deliver mRNA to tissues and organs that goes beyond the capabilities of lipid nanoparticles (LNPs). This polymer-based platform complements Evonik’s existing portfolio of lipid-based drug delivery, including LNPs. Starting this m ... more
09-Jun-2021 CyGenica has announced that it has raised USD $1.4 million in a seed fund investment round, led by global venture capital investor SOSV. The funding round will accelerate validation of CyGenica’s proprietary technology which enables safe, targeted and affordable intercellular drug delivery. ... more
03-Jun-2021 Lonza announced the expansion of its collaboration with Moderna. The expanded collaboration will further extend the manufacture of the drug substance for the COVID-19 Vaccine Moderna and provides for the installation of a new manufacturing line for drug substance production at Lonza’s Gelee ... more
01-Jun-2021 CureVac N.V. announced that the independent Data Safety Monitoring Board (DSMB) has confirmed that the pivotal Phase 2b/3 study (HERALD) for CureVac’s first-generation COVID-19 vaccine candidate, CVnCoV, has passed a first interim analysis at 59 adjudicated COVID-19 cases. The DSMB confirme ... more
26-May-2021 Numab Therapeutics AG, a clinical stage biopharmaceutical company developing next-generation multispecific antibody-based immunotherapies for cancer and inflammation, announced the closing of a CHF 100 million (approximately USD 110 million) Series C financing. The financing was co-led by n ... more
26-May-2021 AiCuris Anti-infective Cures AG announced that the Supervisory Board appointed Dr. Stefan Oschmann as chairman. He succeeds Helmut Jeggle, Chief Executive Officer of Salvia GmbH, who stepped down as planned from his role as Interim-Chairman of the initial Supervisory Board of AiCuris AG. He ... more
26-May-2021 An international research team has shown that optogenetic therapy has helped to partially regain visual function in a patient with retinitis pigmentosa. This is a milestone towards a gene therapy that could restore vision. Clinical trial results show for the first time that optogenetic meth ... more
20-May-2021 BD (Becton, Dickinson and Company) will build a €165 million ($200 million USD) high-tech manufacturing facility in the city of Zaragoza, located in the Aragon region of Spain, that will create up to 600 jobs by 2030. BD plans to begin construction of the new plant in late 2021, and the new ... more
20-May-2021 Infrastructure at the university promoting start-ups and contacts in the business community has a positive effect on the start-up success of scientists. This is the result of a study by the IfM Bonn, which examined the start-up behaviour of academics at German universities over a period of ... more
15-Jun-2021 In addition to plaques that accumulate outside of nerve cells in the brain, Alzheimer’s disease is also characterised by changes inside these cells. Researchers from the Cell Signalling research group at the Chair of Molecular Biochemistry at RUB, headed by Dr. Thorsten Müller, have been st ... more
15-Jun-2021 For the first time in the world, researchers at Tel Aviv University developed an innovative nanotechnology that transforms a transparent calcite nanoparticle into a sparkling gold-like particle. In other words, they turned the transparent particle into a particle that is visible despite its ... more
15-Jun-2021 Both during and after infection with the Coronavirus SARS-CoV-2, patients may suffer from severe neurological symptoms, including “anosmia”, the loss of taste and smell typically associated with COVID-19. Along with direct damage caused by the virus, researchers suspect a role for excessive ... more
14-Jun-2021 Viruses have always had a major influence on life. They emerged a few billion years ago, precisely when is difficult to estimate. There are also several theories as to how viruses originated. While exploring one possibility, researchers at ETH Zurich have managed to recapitulate a potential ... more
14-Jun-2021 Cardiovascular diseases are the most common cause of death in Germany. Important triggers for this are stress, lack of exercise and an unhealthy diet. Now a research team led by Professor Dr. Dietmar Manstein, Director of the Institute of Biophysical Chemistry at Hannover Medical School (MH ... more
14-Jun-2021 Tuberculosis is still the infectious disease that is responsible for the highest number of deaths worldwide. It is caused by Mycobacterium tuberculosis, a bacterium that infects cells in the lungs. There, the pathogen is hardly accessible to most antibiotics. In addition, resistance to exis ... more
11-Jun-2021 Several different causes of ageing have been discovered, but the question remains whether there are common underlying mechanisms that determine ageing and lifespan. Researchers from the Max Planck Institute for Biology of Ageing and the CECAD Cluster of Excellence in Ageing research at the ... more
11-Jun-2021 Bacteriophages are still a relatively unknown component of the human microbiome. However, they can play a powerful role in the life cycles of bacteria. Biochemist Thomas Böttcher from the University of Vienna and PhD student Magdalena Jancheva were able to show for the first time how Pseudo ... more
10-Jun-2021 Our genetic material is stored in our cells in a specific way to make the meter-long DNA molecule fit into the tiny cell nucleus of each body cell. An international team of researchers at the Max Planck Institute for Biology of Ageing, the CECAD Cluster of Excellence in Ageing research at t ... more
09-Jun-2021 ETH Zurich researchers have developed a gene switch that can be operated with the green LED light emitted by commercial smartwatches. This revolutionary approach could be used to treat diabetes in the future. Many modern fitness trackers and smartwatches feature integrated LEDs. The green l ... more
What happens in brain cells affected by Alzheimer’s disease?
Hope in the fight against cancer: They build proteins that are not known to ...
Evonik to market and develop new drug delivery platform for mRNA and gene th ...
Remote-controlled labs - Lab of the future is liberating scientists from the ...
Efficiently "switching on" bacteria to produce high-value chemicals
Clever biomolecular labelling enables identification of immune cells
New study into green tea's potential to help tackle COVID-19
01-Jun-2021 CureVac N.V. announced that the independent Data Safety Monitoring Board (DSMB) has confirmed that the pivotal Phase 2b/3 study (HERALD) for CureVac’s first-generation COVID-19 vaccine candidate, CVnCoV, has passed a first interim analysis at 59 adjudicated COVID-19 cases. The DSMB confirme ... more
Fast onset of strong neutralizing antibody titers after first vaccination
14-May-2021 CureVac N.V. announced together with its collaboration partner GSK, first preclinical data in a rat model, showing that its second-generation COVID-19 vaccine candidate, CV2CoV, induces high levels of antigen production as well as strong and dose-dependent immune responses in vaccinated ani ... more
Product candidate ATR-002 could help hospital patients with COVID-19 avoid ventilation and intensive care treatment
27-Apr-2021 Atriva Therapeutics GmbH has secured up to €11.4 million in federal funding. The company, founded in 2015, announced today that it was selected for research funding from the German Federal Ministry of Education and Research (BMBF). Atriva will use the funds to advance its drug ATR-002 towar ... more
Basel-based biotech startup has big ideas for the future: it aims to take protein engineering into a new era
15-Jun-2021 Using chemical synthesis, Bright Peak Therapeutics can produce proteins that have never before existed. This holds great potential for cancer immunotherapy. The Basel-based spin-off has its beginnings at ETH Zurich. Jeffrey Bode’s long, bold journey began over an after-work beer in Tokyo ... more
11-Jun-2021 In response to the investment boom in the pharmaceutical industry, TTP Group is opening another Pharmaplan branch in Switzerland in the third quarter of 2021. With the new subsidiary at the biotech site in Visp, Pharmaplan is meeting the growing global demand for pharmaceutical engineering ... more
Production interruption with the exception of the two sites in Spain
25-May-2021 The Siegfried Group's IT network has become the target of a malware attack. The company immediately initiated extensive measures to ensure the safety of its employees and facilities at all times and to avert further damage. The root cause has been identified and the recovery of the systems ... more
Does the cost correspond to the particular drug’s effectiveness in combating the disease?
05-May-2020 Do high prices of some cancer medicines have a higher benefit than those drugs with lower prices? An international UZH study has concluded that, in general, there is no correlation between costs of a cancer drugs and their clinical benefit. The researchers are therefore calling for the clin ... more
13-Jun-2017 In a study of 10 high-income countries with universal health care, costs for prescription drugs in 6 of the largest categories of primary care medicines varied by more than 600%. All countries except Canada offered universal coverage of outpatient prescription drugs. The study looked at dat ... more
18-Mar-2015 Cell Medica announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s cancer immunotherapy treatment, referred to as CMD-003, under development for Epstein-Barr Virus (EBV) positive non-Hodgkin lymphomas. Additionally, the company announ ... more
Studies on tissue from patients and mini-brains made from stem cells shed light on the disease
15-Jun-2021 In addition to plaques that accumulate outside of nerve cells in the brain, Alzheimer’s disease is also characterised by changes inside these cells. Researchers from the Cell Signalling research group at the Chair of Molecular Biochemistry at RUB, headed by Dr. Thorsten Müller, have been st ... more
Basel-based biotech startup has big ideas for the future: it aims to take protein engineering into a new era
15-Jun-2021 Using chemical synthesis, Bright Peak Therapeutics can produce proteins that have never before existed. This holds great potential for cancer immunotherapy. The Basel-based spin-off has its beginnings at ETH Zurich. Jeffrey Bode’s long, bold journey began over an after-work beer in Tokyo ... more
Breakthrough in metamaterials: New material can serve as a platform for innovative cancer treatments
15-Jun-2021 For the first time in the world, researchers at Tel Aviv University developed an innovative nanotechnology that transforms a transparent calcite nanoparticle into a sparkling gold-like particle. In other words, they turned the transparent particle into a particle that is visible despite its ... more
26-May-2021 AiCuris Anti-infective Cures AG announced that the Supervisory Board appointed Dr. Stefan Oschmann as chairman. He succeeds Helmut Jeggle, Chief Executive Officer of Salvia GmbH, who stepped down as planned from his role as Interim-Chairman of the initial Supervisory Board of AiCuris AG. He ... more
Chris Round will leading the US and Canada Healthcare business
19-May-2021 Merck announced changes in its operating model for the Healthcare business sector. Chris Round will become President of EMD Serono leading the North America Healthcare business; Andrew Paterson will assume the position of Chief Marketing Officer; and recruitment is ongoing for the position ... more
06-May-2021 CatalYm GmbH, a biopharmaceutical company developing novel cancer immunotherapies, announced the appointment of Dr. Phil L’Huillier as Chief Executive Officer (CEO), effective May 17, 2021. Dr. Phil L’Huillier brings over two decades of experience in executive leadership positions in the ph ... more
California-based startup Strateos closes $56 Million Series B financing
10-Jun-2021 Strateos, Inc., a pioneer in the development of remote access laboratories and lab control software for life science research, announced the closing of its $56.1 million Series B financing led by DCVC and Lux Capital with participation from new investors including Eli Lilly and Company, All ... more
Indo-Irish Biotech Startup Secures Funding to Accelerate Cancer and Rare Genetic Disease Therapy
09-Jun-2021 CyGenica has announced that it has raised USD $1.4 million in a seed fund investment round, led by global venture capital investor SOSV. The funding round will accelerate validation of CyGenica’s proprietary technology which enables safe, targeted and affordable intercellular drug delivery. ... more
Start-up connects bioengineers with nature to hack entirely new organisms, freeing manufacturers from petrochemical dependency
02-Jun-2021 Origin.Bio-- a synthetic biology company that replicates and improves ingredients from traditional chemical industrialisation processes, freeing manufacturers from petrochemical dependency -- today announces a $15m funding round led by EQT Ventures. Existing investor BlueYard Capital also p ... more
Evonik and Stanford University sign research collaboration
11-Jun-2021 Evonik is working with Stanford University on a technology to deliver mRNA to tissues and organs that goes beyond the capabilities of lipid nanoparticles (LNPs). This polymer-based platform complements Evonik’s existing portfolio of lipid-based drug delivery, including LNPs. Starting this m ... more
03-Jun-2021 Lonza announced the expansion of its collaboration with Moderna. The expanded collaboration will further extend the manufacture of the drug substance for the COVID-19 Vaccine Moderna and provides for the installation of a new manufacturing line for drug substance production at Lonza’s Gelee ... more
LanzaTech and BASF achieve first milestone in utilizing industrial off-gases for chemical production
14-May-2021 Transforming the carbon contained in industrial off-gases into valuable chemicals is the aim of a partnership between LanzaTech and BASF. Now the partners have achieved a key first success: With the help of special bacteria, they have been able to produce n-octanol at laboratory scale from ... more
Biotechnology start-up reaches commercialization stage for its technology
06-Apr-2021 Evonik has made a follow-up investment in the biotechnology start-up In Ovo through its venture capital unit. The investment comes as the young company reaches the commercialization stage for its technology and is bringing its gender-testing machine for eggs to the market. Together with co- ... more
Study shows correlation between Twitter sentiment and the valuation of start-ups by venture capitalists
18-Feb-2021 The short message service Twitter has played a prominent role in US politics in recent weeks and months and attracted a lot of attention. Even in business, Twitter users' tweets are being closely followed and used as a basis for decision-making. A new study shows that venture capitalists ca ... more
Strengthening LGC'S offer to the IVD sector
10-Jul-2020 LGC announced the acquisition of The Native Antigen Company (NAC), supplier of high quality infectious disease antigens and antibodies. NAC is a developer, manufacturer and supplier of critical reagents to the in vitro diagnostic (IVD), pharmaceutical and academic sectors. It offers a compr ... more
27-Nov-2019 Merck announced that the Japan Patent Office and the Intellectual Property Office of Singapore have each allowed the company’s patent application for the use of paired CRISPR nickases, bringing Merck’s number of patents to 22 worldwide. “Paired nickases represent a significant step in incre ... more
15-Mar-2019 ECHA’s Committee for Socio-economic Analysis (SEAC) adopted its final opinion supporting the proposal by Denmark, Italy, Norway and ECHA to restrict the placing on the market of tattoo inks and permanent make-up. Substances within the scope of the restriction include carcinogenic, mutagenic ... more
05-Mar-2019 Merck announced that the Canadian Patent Office has allowed Merck’s patent application directed to the use of paired CRISPR nickases in eukaryotic cells. The patent provides an important and more specific solution for scientists who need accurate methods when developing treatments for diffi ... more
Race for COVID-19 vaccine
13-Jul-2020 In the first half of this year, the transaction volume of mergers and acquisitions in the chemical and life sciences industries has decreased dramatically. The volume of deals announced in the first six months is only $84 billion. Compared to the previous year (389 billion dollars), this is ... more
'Embarrassing' or stigmatized cancers like lung and liver are underfunded
23-Jul-2019 Many of the deadliest or most common cancers get the least amount of nonprofit research funding, according to a new Northwestern Medicine study that examined the distribution of nonprofit research funding in 2015 across cancer types. Colon, endometrial, liver and bile duct, cervical, ovaria ... more
22-Jul-2019 According to latest research by FMI, the global gene editing tools market is estimated to have accounted for more than US$ 258 Mn in terms of value in 2018. The report on the gene editing tools market further projects that the gene editing tools market is likely to grow at a CAGR of over 18 ... more
The new administration has inherited a global pandemic and worsening climate change, among other science-related issues
10-Feb-2021 The inauguration of Joe Biden and Kamala Harris marks a new era for science policy in the U.S. and beyond. The new administration has inherited a global pandemic and worsening climate change, among other science-related issues. A cover story in Chemical & Engineering News (C&EN), the weekly ... more
15-Mar-2019 ECHA’s Committee for Socio-economic Analysis (SEAC) adopted its final opinion supporting the proposal by Denmark, Italy, Norway and ECHA to restrict the placing on the market of tattoo inks and permanent make-up. Substances within the scope of the restriction include carcinogenic, mutagenic ... more
Toxicity testing of microparticles and poorly soluble liquids in the water environment
15-Jan-2019 A Task Force set up by the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) has provided new insights into scientific testing for the impact of undissolved particles in the aquatic environment. ECETOC launched the Task Force in response to increasing concerns among the ... more
31-May-2021 The Siegfried Group has largely overcome the consequences of the cyber attack that occurred shortly before Pentecost and has begun to ramp up production again. Some sites had continued or resumed operations to a certain extent last week. Other sites will follow in the next days, including t ... more
Production interruption with the exception of the two sites in Spain
25-May-2021 The Siegfried Group's IT network has become the target of a malware attack. The company immediately initiated extensive measures to ensure the safety of its employees and facilities at all times and to avert further damage. The root cause has been identified and the recovery of the systems ... more
Support Ongoing Strong Growth of Pre-Filled Drug Delivery Business
20-May-2021 BD (Becton, Dickinson and Company) will build a €165 million ($200 million USD) high-tech manufacturing facility in the city of Zaragoza, located in the Aragon region of Spain, that will create up to 600 jobs by 2030. BD plans to begin construction of the new plant in late 2021, and the new ... more
Around 250 vacancies at all locations by the end of 2019
26-Apr-2019 The Eppendorf Group is creating around 250 new jobs worldwide this year. A large proportion of the new jobs will be created in Hamburg at the headquarters of the globally active life sciences company and is an important component of Eppendorf's growth strategy. "Eppendorf is growing strongl ... more
12-Apr-2019 Income and social status have an increasing effect on life expectancy in Germany. On average, men with very low retirement pay die five years earlier than those who are much better off. Poverty shortens life. According to a study by researchers at the Max Planck Institute for Demographic Re ... more
28-Feb-2019 In the study "Leading Employers Germany 2019", the Berlin-based manufacturer of high-tech laboratory measuring instruments KNAUER was ranked as one of the best employers for the second time. This makes KNAUER one of the companies with the best ratings in an independent meta-study conducted ... more
USA
Germany
United Kingdom
Switzerland
France
Belgium
Canada
Sweden
Netherlands
Austria
Japan
Denmark
Australia
Spain
China
Israel
Finland
Norway
Singapore
Italy
Korea, Republic of (South Korea)
India
Russian Federation
Ireland
Luxembourg
Brazil
Poland
New Zealand
Viet Nam
Malaysia
South Africa
Taiwan
Hong Kong
© 1997-2021 LUMITOS AG, All rights reserved
